ACADIA PHARMACEUTICALS INC (ACAD) Institutional Shareholders

ACADIA PHARMACEUTICALS INC (ACAD) is currently reported in institutional portfolios tracked by InsiderSet based on the latest available SEC Form 13F filings for the quarter ended June 30, 2026. The institutional investors covered on this page collectively reported approximately $3.62B in ACAD holdings during the latest filing period.

Baker Bros. Advisors Lp is currently the largest disclosed institutional shareholder of ACAD tracked by InsiderSet, reporting ownership valued at approximately $954.88M in its March 31, 2026 SEC Form 13F filing. Based on current market prices and the latest disclosed share count, the position is now estimated to be worth approximately $1.11B, representing an estimated gain of +16.22% since the filing period.

The top 10 institutional shareholders tracked on this page collectively account for approximately 66% of the total disclosed ACAD value among the investors covered in this analysis. Major shareholders include Baker Bros. Advisors Lp, Blackrock, Inc., Vanguard Portfolio Management Llc, and several other long-term asset managers with concentrated positions in ACADIA PHARMACEUTICALS INC (ACAD).

This page ranks the largest institutional ACAD shareholders using publicly disclosed SEC Form 13F data, including reported values, estimated current holding values, portfolio allocation percentages, ownership concentration metrics, and historical holding changes across major hedge funds and investment firms.

Institutional Holders

334

Total Reported Value

$3.62B

Largest Holder

Baker Bros. Advisors Lp

Largest Position

$954.88M

Insider Transactions (90d)

12

Latest Filing Quarter

Q2 2026

New Institutional Positions

47

Funds Exiting Positions

0

Page 1 of 7
NameInvestor/ManagerPortfolio %QuantityReported BalanceCurrent Estimated ValueGain/loss Since FilingEstimated Portfolio Performance
Baker Bros. Advisors Lp5.48%42,896,690$954,880,319$1,109,737,370+$154,857,051+16.22%
Blackrock, Inc.0.01%21,550,921$479,723,502$557,522,326+$77,798,824+16.22%
Vanguard Portfolio Management Llc0.01%8,671,645$193,030,818$224,335,456+$31,304,638+16.22%
State Street Corp0.01%8,332,771$185,487,482$215,568,786+$30,081,304+16.22%
Rtw Investments, Lp1.58%7,144,524$159,037,104$184,828,836+$25,791,732+16.22%
Vanguard Capital Management Llc0.00%5,661,400$126,022,764$146,460,418+$20,437,654+16.22%
Geode Capital Management, Llc0.00%3,464,689$77,137,406$89,631,504+$12,494,098+16.20%
First Trust Advisors Lp0.05%3,343,868$74,434,501$86,505,865+$12,071,364+16.22%
Dimensional Fund Advisors Lp0.01%3,155,160$70,221,842$81,623,989+$11,402,147+16.24%
Palo Alto Investors Lp9.78%2,872,695$63,946,191$74,316,620+$10,370,429+16.22%
Point72 Asset Management, L.P.0.10%2,577,916$57,384,410$66,690,687+$9,306,277+16.22%
Braidwell Lp1.84%2,471,199$55,008,890$63,929,918+$8,921,028+16.22%
Pictet Asset Management Holding Sa0.05%1,983,198$50,146,450$51,305,332+$1,158,882+2.31%
Renaissance Technologies LLCJim Simons0.06%1,724,196$38,380,603$44,604,951+$6,224,348+16.22%
Arrowstreet Capital, Limited Partnership0.02%1,569,491$34,936,870$40,602,732+$5,665,862+16.22%
Goldman Sachs Group Inc0.00%1,557,804$34,676,717$40,300,389+$5,623,672+16.22%
Bank Of America Corp0.00%1,553,770$34,586,921$40,196,030+$5,609,109+16.22%
Frazier Life Sciences Management, L.P.0.82%1,438,198$32,014,287$37,206,182+$5,191,895+16.22%
Artisan Partners Limited Partnership0.05%1,331,813$29,646,157$34,454,002+$4,807,845+16.22%
Fred Alger Management, Llc0.12%1,277,151$28,429,382$33,039,896+$4,610,514+16.22%
Northern Trust Corp0.00%1,272,611$28,328,322$32,922,447+$4,594,125+16.22%
Charles Schwab Investment Management Inc0.00%1,173,560$26,123,446$30,359,997+$4,236,551+16.22%
Morgan Stanley0.00%1,093,151$24,333,551$28,279,816+$3,946,265+16.22%
Nuveen, Llc0.01%1,036,987$23,083,330$26,826,854+$3,743,524+16.22%
Rockefeller Capital Management L.P.0.04%1,027,357$22,868,967$26,577,726+$3,708,759+16.22%
Massachusetts Financial Services Co0.01%855,435$21,642,506$22,130,103+$487,597+2.25%
Allspring Global Investments Holdings, Llc0.04%954,855$21,312,363$24,702,099+$3,389,736+15.91%
Qube Research & Technologies Ltd0.03%950,299$21,153,656$24,584,235+$3,430,579+16.22%
Vanguard Fiduciary Trust Co0.00%875,720$19,493,527$22,654,876+$3,161,349+16.22%
Deutsche Bank Ag\0.01%840,414$18,707,616$21,741,510+$3,033,894+16.22%
Invesco Ltd.0.00%836,510$18,620,713$21,640,514+$3,019,801+16.22%
Jane Street Group, Llc0.02%803,265$17,880,679$20,780,466+$2,899,787+16.22%
Two Sigma Investments, Lp0.01%775,121$17,254,193$20,052,380+$2,798,187+16.22%
Principal Financial Group Inc0.01%768,224$17,100,666$19,873,955+$2,773,289+16.22%
Logos Global Management Lp0.86%750,000$16,695,000$19,402,500+$2,707,500+16.22%
Bank Of New York Mellon Corp0.00%736,558$16,395,781$19,054,755+$2,658,974+16.22%
Fisher Asset Management, Llc0.01%732,872$16,313,745$18,959,399+$2,645,654+16.22%
D. E. Shaw & Co., Inc.0.01%729,836$16,246,149$18,880,857+$2,634,708+16.22%
Allianz Asset Management Gmbh0.02%706,664$15,730,341$18,281,398+$2,551,057+16.22%
Millennium Management Llc0.01%705,461$15,703,562$18,250,276+$2,546,714+16.22%
Panagora Asset Management Inc0.06%688,649$15,329,327$17,815,350+$2,486,023+16.22%
Woodline Partners Lp0.06%676,401$15,056,686$17,498,494+$2,441,808+16.22%
Ameriprise Financial Inc0.00%624,260$13,902,840$16,149,606+$2,246,766+16.16%
Citadel Advisors Llc0.01%622,760$13,862,637$16,110,801+$2,248,164+16.22%
Rice Hall James & Associates, Llc0.77%617,489$13,745,305$15,974,440+$2,229,135+16.22%
Voya Investment Management Llc0.01%613,784$13,662,832$15,878,592+$2,215,760+16.22%
Manufacturers Life Insurance Company, The0.01%571,776$12,727,734$14,791,845+$2,064,111+16.22%
Aqr Capital Management Llc0.01%527,913$11,751,343$13,657,109+$1,905,766+16.22%
Jupiter Asset Management Ltd0.06%491,093$10,931,730$12,704,576+$1,772,846+16.22%
Ubs Group Ag0.00%448,549$9,984,702$11,603,963+$1,619,261+16.22%

Frequently asked questions about ACAD

  • Who owns the most ACAD stock?

    The largest holders of ACAD are typically major institutional investors such as asset managers and hedge funds reporting on Form 13F. The table above ranks tracked superinvestors by reported position size using the latest available filings for ACADIA PHARMACEUTICALS INC (ACAD).

  • Is ACAD widely held by superinvestors?

    Many widely followed stocks like ACAD appear across numerous superinvestor portfolios because of liquidity, index inclusion, and fundamentals. The holder count and table above show how broadly ACAD is represented among the institutional managers we track.

  • What do “Current Estimated Value”, “Gain/loss Since Filing”, and “Estimated Portfolio Performance” mean?

    Current Estimated Value is reported share quantity from the latest 13F times our most recent split-adjusted U.S. session close. Gain/loss Since Filing is that estimate minus the reported 13F dollar value; Estimated Portfolio Performance is that difference as a percent of the reported value. Green means the estimate is above the filing value; red means below (not purchase cost). If many filers share the same implied filing price per share, the performance % may match across rows. These are not official fund marks or live quotes.